Data / Form D filings / VIRxSYS Corp
VIRxSYS Corp: Form D filings
VIRxSYS Corp, a biotechnology company in Gaithersburg, MD, filed 4 Form D notices with the SEC between 2009 and 2011. The latest, on December 22, 2011, reports $999,999 sold of a $30 million offering to 10 investors.
Find out what VIRxSYS Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 PERRY PARKWAY, SUITE 1A, Gaithersburg, MD, 20877
- Phone
- (301) 987-0480
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1081596
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 22, 2011 | New notice | $30,000,000 | $999,999 | $29,000,001 | 10 | Nov 10, 2011 | sec.gov |
| Apr 7, 2011 | Amendment | $45,000,000 | $33,814,349 | $11,185,651 | 276 | Oct 27, 2009 | sec.gov |
| Apr 12, 2010 | Amendment | $45,000,000 | $9,807,916 | $35,192,084 | 114 | Oct 27, 2009 | sec.gov |
| Nov 4, 2009 | New notice | $40,000,000 | $9,807,916 | $30,192,084 | 114 | Oct 27, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| William Sick | Director | |
| William Turner | Director | |
| William McIntosh | Director | |
| James Kehoe | Director | |
| Prince Zachariah | Director | |
| Lawrence Michaelis | Executive Officer, Director | |
| John Phair | Director | |
| Franz Schmadl | Director | |
| Helmer Agersborg | Director | |
| Robert Ackmann | Executive Officer |
Other biotechnology companies in Maryland that filed recently
- BlueHealer Inc. $1 · Nov 4, 2026
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
- Uvantis Therapeutics, Inc. $100,000 · Sep 23, 2026
- Gliknik Inc $15 million · Sep 17, 2026
- Georgiamune, Inc. $92.7 million · Aug 17, 2026
Every Form D from the week of Dec 19, 2011 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what VIRxSYS Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.